Back
180 Life Sciences Vs. Altimmune Industry Stock Comparison
Sell
17
ATNF
180 Life Sciences
Last Price:
1.70
Seasonality Move:
-36.3%
Sell
29
ALT
Altimmune
Last Price:
6.47
Seasonality Move:
9%
Sell
17
180 Life Sciences (ATNF)
is a Sell
Is 180 Life Sciences a Buy, Sell or Hold?
- The current 180 Life Sciences [ATNF] share price is $1.68. The Score for ATNF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- ATNF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Altimmune (ALT)
is a Sell
Is Altimmune a Buy, Sell or Hold?
- The current Altimmune [ALT] share price is $6.47. The Score for ALT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ALT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATNF Stock Price Chart
What is 180 Life Sciences's stock price today?
-
The 180 Life Sciences share price today is $1.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNF is experiencing selling pressure, which indicates risk of future bearish movement.
ATNF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.11 | Sell |
| Chaikin Money Flow: | -32384 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.76 - 2.06) | Sell |
| Bollinger Bands (100): | (1.6 - 2.14) | Sell |
ALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 42.07 | Sell |
| Chaikin Money Flow: | -2147602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.48 - 7.42) | Sell |
| Bollinger Bands (100): | (6.24 - 7.56) | Sell |
ATNF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.87 | Sell |
| 20-day SMA: | 1.9 | Sell |
| 50-day SMA: | 1.95 | Sell |
| 200-day SMA: | 2.56 | Sell |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.88 | Sell |
| 50-day EMA: | 1.91 | Sell |
| 200-day EMA: | 10.16 | Sell |
ALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.18 | Sell |
| 20-day SMA: | 7.01 | Sell |
| 50-day SMA: | 6.67 | Sell |
| 200-day SMA: | 8.13 | Sell |
| 8-day EMA: | 7.01 | Sell |
| 20-day EMA: | 7.02 | Sell |
| 50-day EMA: | 6.9 | Sell |
| 200-day EMA: | 7.09 | Sell |
180 Life Sciences Earnings Growth & ATNF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.00 per share, and a decrease next year of $0.00 per share.
Altimmune Earnings Growth & ALT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.
180 Life Sciences Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Altimmune Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||